IL273479B2
Pharmaceutical compositions with enhanced permeation
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2005042271A1 | Cites | United States of America | XY | Search report | 1-4,6-8,15,19-21,25,28 |
| US2005266085A1 | Cites | United States of America | XY | Search report | 1-4,6-43 |
| US2014316333A1 | Cites | United States of America | Y | Search report | 5 |
| US8840935B2 | Cites | United States of America | XY | Search report | 1-4,6-43 |
34 members in 9 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 15717856 | United States of America | – | |
| 201715717856 | United States of America | A | |
| 15724234 | United States of America | – | |
| 201715724234 | United States of America | A | |
| 62735822 | United States of America | – | |
| 201862735822 | United States of America | P | |
| 2018053026 | United States of America | W |
Members34
| Document | Office | Kind | |
|---|---|---|---|
| US2017290776A1 | United States of America | A1 | |
| CA3022797A1 | Canada | A1 | |
| WO2017192923A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2018200198A1 | United States of America | A1 | |
| IL262751A | Israel | A | |
| IL262751D0 | Israel | D0 | |
| KR20190005198A | Republic of Korea | A | |
| US2019022022A1 | United States of America | A1 | |
| CN109310647A | China | A | |
| BR112018072467A2 | Brazil | A2 | |
| EP3452024A1 | European Patent Office (EPO) | A1 | |
| CA3076815A1 | Canada | A1 | |
| WO2019067667A1 | World Intellectual Property Organization (WIPO) | A1 | |
| JP2019519488A | Japan | A | |
| CN111132670A | China | A | |
| KR20200060457A | Republic of Korea | A | |
| IL273479A | Israel | A | |
| IL273479D0 | Israel | D0 | |
| EP3687509A1 | European Patent Office (EPO) | A1 | |
| BR112020005967A2 | Brazil | A2 | |
| JP2020535176A | Japan | A | |
| US11273131B2 | United States of America | B2 | |
| KR102536696B1 | Republic of Korea | B1 | |
| JP2023134518A | Japan | A | |
| JP2024012484A | Japan | A | |
| JP7431724B2 | Japan | B2 | |
| IL262751B1 | Israel | B1 | |
| IL318880A | Israel | A | |
| IL262751B2 | Israel | B2 | |
| IL273479B1 | Israel | B1 | |
| IL321263A | Israel | A | |
| KR102845228B1 | Republic of Korea | B1 | |
| KR20250126144A | Republic of Korea | A | |
| IL273479B2This record | Israel | B2 |
Numbers
- Publication
- 273479
- Application
- 273479
Titles2
- English
- PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
- Hebrew
- תכשירי רוקחות עם חדירות משופרת
Classification
- CPC, 18
- A61K9/006
- A61K9/7007
- A61K31/05
- A61K31/137
- A61K31/085
- A61K31/11
- A61K31/192
- A61K31/357
- A61K31/5513
- A61K31/5517
- A61K2300/00
- A61K47/06
- A61K47/44
- A61K47/10
- A61K47/46
- A61K47/38
- A61P25/08
- A61K47/12
- IPC, 17
- A61K31 192
- A61K9 70
- A61K47 46
- A61K47 10
- A61K47 12
- A61K47 38
- A61K47 06
- A61K47 44
- A61K9 00
- A61P25 08
- A61K31 11
- A61K31 357
- A61K31 05
- A61K31 5513
- A61K31 085
- A61K31 137
- A61K31 5517